Sen. Fetterman Calls Himself ‘Advocate of Psychedelics,’ Promotes Mushrooms For PTSD

High Times ^ | 6/12/23 | Thomas Edward

[Georgia Girl 2]

Do not start taking mushrooms. That stuff is terrible for you! Not that I ever took shrooms or anything. 😐

[dfwgator]

I’ll stick to licking toads.

I mean somebody had to be the first to lick a toad. How does one come up with that idea?

[dfwgator]

Now it appears he had it remove when in the hospital recently but never mentioned the fact he had surgery to remove the lipoma because the large lump is not noticeable.

I wonder if they brought in Dr. Pimple Popper?

[Lazamataz]

The thing about shrooms is that they are utterly unpredictable. One time a gram won’t barely hit you, another time it will have you flat on your back babbling about purple zebras and the choreography of chili peppers.

[BipolarBob]

You could say that about a lot of things. Like eating bath salts. Tide Pod Challenge.

[Georgia Girl 2]

When I wasn’t doing them there was no counting out a gram. 😆

[cookcounty]

Obviously has done wonders for him! Such sharp clarity!

[vpintheak]

Well, in all honestly, it’s not just your state. You just happen to be one of the most visible right now. We are all in for it.
I strongly feel that the USA is being judged by God right now, it is really only a matter of time.

[Texan4Life]

Psychedelic drug MDMA eases PTSD symptoms in a study that paves the way for possible US approval

https://apnews.com/article/mdma-ecstasy-ptsd-study-molly-fda-1155a374305027567d5f41910022022d

The psychedelic drug MDMA can reduce symptoms of post-traumatic stress disorder, researchers reported in a new study published Thursday.

The company sponsoring the research said it plans later this year to seek U.S. approval to market the drug, also known as ecstasy, as a PTSD treatment when combined with talk therapy.

“It’s the first innovation in PTSD treatment in more than two decades. And it’s significant because I think it will also open up other innovation,” said Amy Emerson, CEO of MAPS Public Benefit Corporation, the research sponsor.

Earlier this year, Australia became the first country to allow psychiatrists to prescribe MDMA and psilocybin, the psychoactive ingredient in psychedelic mushrooms. The drugs are gaining wider cultural acceptance in the U.S. in part because of efforts by the nonprofit advocacy group Multidisciplinary Association for Psychedelic Studies.